| Group 1: | Healthy normal rats were treated only 5% DMSO |
| Group 2: | Healthy normal rats were treated 8 mg kg−1 of galangin |
| Group 3: | STZ-induced hyperglycemic control rats |
| Group 4: | Hyperglycemic rats were treated 8 mg kg−1 of galangin |
| Group 5: | Hyperglycemic rats were treated 600 µg kg−1 of glibenclamide |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.